O
OEX SA
WSE:OEX
OEX SA
WSE:OEX
Price:
53.6
PLN
Market Closed
Market Cap:
zł366.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
OEX SA
WSE:OEX
|
PL |
|
UGI Corp
NYSE:UGI
|
US |
|
G
|
GIB Capital Group Inc
OTC:GIBX
|
US |
|
J
|
Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518
|
CN |
|
Plexus Corp
NASDAQ:PLXS
|
US |
|
Alliance Healthcare Group Ltd
SGX:MIJ
|
SG |
Balance Sheet
Balance Sheet Decomposition
OEX SA
OEX SA
Balance Sheet Decomposition is not available for
OEX SA
OEX SA
Balance Sheet
OEX SA
OEX SA
Currency: PLN
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
5
|
5
|
11
|
27
|
56
|
52
|
60
|
107
|
94
|
|
| Cash |
1
|
5
|
5
|
10
|
27
|
56
|
52
|
60
|
107
|
93
|
|
| Cash Equivalents |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
41
|
70
|
71
|
122
|
137
|
116
|
127
|
123
|
135
|
139
|
|
| Accounts Receivables |
40
|
67
|
67
|
115
|
124
|
87
|
88
|
108
|
117
|
122
|
|
| Other Receivables |
0
|
3
|
4
|
7
|
13
|
29
|
39
|
15
|
18
|
18
|
|
| Inventory |
13
|
17
|
25
|
23
|
9
|
4
|
9
|
13
|
11
|
13
|
|
| Other Current Assets |
0
|
4
|
9
|
11
|
8
|
4
|
0
|
47
|
2
|
3
|
|
| Total Current Assets |
54
|
96
|
111
|
167
|
180
|
180
|
189
|
243
|
256
|
250
|
|
| PP&E Net |
5
|
14
|
14
|
23
|
25
|
88
|
82
|
78
|
91
|
100
|
|
| PP&E Gross |
5
|
14
|
14
|
23
|
25
|
88
|
82
|
78
|
91
|
100
|
|
| Accumulated Depreciation |
11
|
15
|
17
|
20
|
23
|
11
|
11
|
11
|
14
|
20
|
|
| Intangible Assets |
1
|
7
|
8
|
12
|
17
|
16
|
21
|
17
|
18
|
12
|
|
| Goodwill |
58
|
68
|
75
|
117
|
117
|
80
|
81
|
79
|
79
|
85
|
|
| Note Receivable |
1
|
1
|
1
|
1
|
1
|
6
|
13
|
8
|
7
|
6
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
15
|
24
|
15
|
|
| Other Long-Term Assets |
1
|
2
|
2
|
6
|
14
|
13
|
10
|
8
|
10
|
11
|
|
| Other Assets |
58
|
68
|
75
|
117
|
117
|
80
|
81
|
79
|
79
|
85
|
|
| Total Assets |
119
N/A
|
188
+58%
|
212
+12%
|
325
+54%
|
355
+9%
|
384
+8%
|
397
+3%
|
448
+13%
|
485
+8%
|
478
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
46
|
56
|
66
|
83
|
76
|
65
|
0
|
74
|
74
|
73
|
|
| Accrued Liabilities |
3
|
7
|
9
|
11
|
10
|
12
|
34
|
40
|
46
|
50
|
|
| Short-Term Debt |
0
|
10
|
4
|
5
|
11
|
9
|
4
|
4
|
3
|
0
|
|
| Current Portion of Long-Term Debt |
5
|
14
|
23
|
38
|
40
|
53
|
40
|
39
|
39
|
36
|
|
| Other Current Liabilities |
1
|
3
|
2
|
38
|
4
|
4
|
75
|
27
|
23
|
24
|
|
| Total Current Liabilities |
55
|
90
|
104
|
175
|
142
|
144
|
153
|
185
|
185
|
184
|
|
| Long-Term Debt |
0
|
3
|
4
|
27
|
54
|
72
|
75
|
74
|
64
|
61
|
|
| Deferred Income Tax |
7
|
8
|
9
|
10
|
10
|
12
|
13
|
12
|
15
|
13
|
|
| Minority Interest |
0
|
2
|
2
|
2
|
2
|
3
|
8
|
13
|
0
|
5
|
|
| Other Liabilities |
0
|
2
|
2
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
63
N/A
|
104
+66%
|
121
+16%
|
218
+81%
|
214
-2%
|
231
+8%
|
249
+8%
|
284
+14%
|
265
-7%
|
264
0%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Retained Earnings |
29
|
36
|
43
|
59
|
75
|
92
|
86
|
98
|
152
|
140
|
|
| Additional Paid In Capital |
25
|
45
|
45
|
45
|
63
|
63
|
63
|
63
|
63
|
63
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
8
|
8
|
16
|
16
|
0
|
|
| Other Equity |
1
|
1
|
1
|
1
|
1
|
5
|
5
|
16
|
19
|
9
|
|
| Total Equity |
57
N/A
|
84
+49%
|
91
+8%
|
107
+18%
|
141
+32%
|
153
+9%
|
147
-4%
|
163
+11%
|
220
+35%
|
214
-3%
|
|
| Total Liabilities & Equity |
119
N/A
|
188
+58%
|
212
+12%
|
325
+54%
|
355
+9%
|
384
+8%
|
397
+3%
|
448
+13%
|
485
+8%
|
478
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5
|
7
|
7
|
7
|
8
|
8
|
8
|
7
|
7
|
7
|
|
Switch to:
Switch to:
See Also
Discover More
